Bridgewater Associates LP Trims Stake in Relx Plc (NYSE:RELX)

Bridgewater Associates LP lessened its holdings in Relx Plc (NYSE:RELX) by 47.5% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 25,050 shares of the technology company’s stock after selling 22,628 shares during the period. Bridgewater Associates LP’s holdings in Relx were worth $1,138,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Raymond James Financial Inc. bought a new position in Relx in the 4th quarter worth about $44,516,000. Bank of Montreal Can grew its holdings in shares of Relx by 290.3% during the fourth quarter. Bank of Montreal Can now owns 886,758 shares of the technology company’s stock worth $40,277,000 after purchasing an additional 659,547 shares in the last quarter. Arrowstreet Capital Limited Partnership increased its position in shares of Relx by 50.3% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 1,968,739 shares of the technology company’s stock worth $89,420,000 after purchasing an additional 658,655 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. purchased a new stake in Relx in the fourth quarter valued at approximately $9,920,000. Finally, ABC Arbitrage SA bought a new stake in Relx during the fourth quarter valued at approximately $6,296,000. Institutional investors own 15.02% of the company’s stock.

Analysts Set New Price Targets

Several analysts have recently weighed in on the stock. Redburn Atlantic began coverage on shares of Relx in a research report on Wednesday, January 8th. They set a “buy” rating on the stock. The Goldman Sachs Group began coverage on Relx in a research report on Wednesday, March 26th. They set a “buy” rating on the stock. StockNews.com cut Relx from a “buy” rating to a “hold” rating in a report on Tuesday, March 4th. Morgan Stanley reissued an “overweight” rating on shares of Relx in a report on Wednesday. Finally, Barclays upgraded Relx from an “equal weight” rating to an “overweight” rating in a research report on Friday, March 14th. One analyst has rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Buy”.

Relx Price Performance

Shares of NYSE:RELX opened at $52.20 on Friday. The company has a quick ratio of 0.47, a current ratio of 0.52 and a debt-to-equity ratio of 1.46. The stock has a market cap of $96.61 billion, a PE ratio of 28.06, a PEG ratio of 2.73 and a beta of 0.84. The company’s fifty day moving average is $49.37 and its 200 day moving average is $48.00. Relx Plc has a 52 week low of $40.25 and a 52 week high of $52.54.

Relx Increases Dividend

The business also recently disclosed a semi-annual dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Friday, May 9th will be issued a $0.5586 dividend. The ex-dividend date of this dividend is Friday, May 9th. This represents a dividend yield of 1.6%. This is an increase from Relx’s previous semi-annual dividend of $0.23. Relx’s payout ratio is currently 59.68%.

About Relx

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.